Government to formulate policy to promote bulk drug manufacturing

NEW DELHI: Government is examining the recommendations of a committee set up to study the issues related to critical active pharmaceutical ingredients (APIs) so as to formulate a policy for promoting their manufacturing in the country.

"The Government has taken various measures to promote 'Make in India' initiative in pharmaceutical sector," and had constituted a Committee under the chairmanship of Secretary, Department of Health Research in this direction, the Minister of Chemicals and Fertilisers Ananth Kumar said in a reply to the Lok Sabha.

He said: "The committee has recommended establishment of Mega Parks for APIs with common facilities such as common effluent treatment plants, testing facilities, captive power plants/assured power supply by state systems, common utilities /services such as storage, testing laboratories, IPR management, designing, guest houses/accommodation etc maintained by a separate special purpose vehicles (SPV)."

The recommendations are being examined for formulation of a policy for promotion of manufacturing of bulk drugs, Kumar said.